Literature DB >> 6270377

Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication.

R M Buller, J E Janik, E D Sebring, J A Rose.   

Abstract

In addition to adenoviruses, which are capable of completely helping adenovirus-associated virus (AAV) multiplication, only herpesviruses are known to provide any AAV helper activity, but this activity has been thought to be partial (i.e., AAV DNA, RNA, and protein syntheses are induced, but infectious particles are not assembled). In this study, however, we show that herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are in fact complete AAV helpers and that AAV type 2 (AAV2) infectivity yields can approach those obtained when coinfections are carried out with a helper adenovirus. AAV helper activity was demonstrated in KB cells with two HSV-1 strains (11124 and 17MP) and an HSV-2 strain (HG52). Each herpesvirus supported AAV2 multiplication with comparable efficiency. AAV2 multiplication was similarly efficient in HSV-1 coinfections of HeLa cells, whereas lower yields were obtained in HEp-2 and primary human embryonic kidney cells. HSV-1 also supported AAV1 multiplication in HeLa cells but, at corresponding multiplicities of infection, AAV1 grew less efficiently than AAV2. Comparisons of the time courses of AAV2 DNA, RNA, and protein syntheses after coinfection with either adenovirus type 5 or HSV-1 revealed that, in each case, the onset of synthesis and attainment of maximal synthesis rate occurred earlier in coinfections with HSV-1. These findings demonstrate the linkage of AAV macromolecular synthesis to an event(s) in the helper virus cycle. Aside from this temporal association, helper-related differences in AAV macromolecular synthesis were not apparent.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270377      PMCID: PMC256613     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  M C Timbury
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

2.  The role of herpesviruses in adenovirus-associated virus replication in vitro.

Authors:  R W Atchison
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

3.  Adenovirus-associated viruses: enhancement by human herpesviruses.

Authors:  N R Blacklow; M D Hoggan; M S McClanahan
Journal:  Proc Soc Exp Biol Med       Date:  1970-09

4.  Serologic evidence for human infection with adenovirus-associated viruses.

Authors:  N R Blacklow; M D Hoggan; W P Rowe
Journal:  J Natl Cancer Inst       Date:  1968-02       Impact factor: 13.506

5.  Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands.

Authors:  K I Berns; J A Rose
Journal:  J Virol       Date:  1970-06       Impact factor: 5.103

6.  Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride.

Authors:  J F Williams
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

7.  Studies of the enhancement of an adenovirus-associated virus by herpes simplex virus.

Authors:  N R Blacklow; R Dolin; M D Hoggan
Journal:  J Gen Virol       Date:  1971-01       Impact factor: 3.891

8.  Adenovirus-associated virus multiplication. 8. Analysis of in vivo transcription induced by complete or partial helper viruses.

Authors:  B J Carter; J A Rose
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

9.  Adenovirus-associated virus multiplication. VII. Helper requirement for viral deoxyribonucleic acid and ribonucleic acid synthesis.

Authors:  J A Rose; F Koczot
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

10.  Immunofluorescent studies of the potentiation of an adenovirus-associated virus by adenovirus 7.

Authors:  N R Blacklow; M D Hoggan; W P Rowe
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

View more
  117 in total

1.  Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Authors:  A K Malik; P E Monahan; D L Allen; B G Chen; R J Samulski; K Kurachi
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Adeno-associated virus RNAs appear in a temporal order and their splicing is stimulated during coinfection with adenovirus.

Authors:  M B Mouw; D J Pintel
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system.

Authors:  P Ward; M Falkenberg; P Elias; M Weitzman; R M Linden
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  PKA/PrKX activity is a modulator of AAV/adenovirus interaction.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

Review 5.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

6.  Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1.

Authors:  Francesca D Franzoso; Michael Seyffert; Rebecca Vogel; Artur Yakimovich; Bruna de Andrade Pereira; Anita F Meier; Sereina O Sutter; Kurt Tobler; Bernd Vogt; Urs F Greber; Hildegard Büning; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

7.  Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein.

Authors:  A Beaton; P Palumbo; K I Berns
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA.

Authors:  Ramnath Nayak; David J Pintel
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 10.  Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma.

Authors:  Jun Yoshida; Masaaki Mizuno
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.